These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

423 related articles for article (PubMed ID: 18687703)

  • 1. Long-term predictors of mortality in ICD patients with non-ischaemic cardiac disease: impact of renal function.
    Schefer T; Wolber T; Binggeli C; Holzmeister J; Brunckhorst C; Duru F
    Europace; 2008 Sep; 10(9):1052-9. PubMed ID: 18687703
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of renal dysfunction on appropriate therapy in implantable cardioverter defibrillator patients with non-ischaemic dilated cardiomyopathy.
    Takahashi A; Shiga T; Shoda M; Manaka T; Ejima K; Hagiwara N
    Europace; 2009 Nov; 11(11):1476-82. PubMed ID: 19661116
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [14-year experience with implantable cardioverter/defibrillators: determination of prognosis and discharge behavior].
    Vester EG; Dees H; Dobran I; Hennersdorf M; Perings C; Heydthausen M; Winter J; Strauer BE
    Z Kardiol; 2000; 89 Suppl 3():194-205. PubMed ID: 10810803
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Survival and appropriate device interventions in recipients of cardioverter defibrillators implanted for the primary versus secondary prevention of sudden cardiac death.
    Stockburger M; Krebs A; Nitardy A; Habedank D; Celebi O; Knaus T; Dietz R
    Pacing Clin Electrophysiol; 2009 Mar; 32 Suppl 1():S16-20. PubMed ID: 19250084
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence and prognostic impact of comorbidities in heart failure patients with implantable cardioverter defibrillator.
    Bruch C; Bruch C; Sindermann J; Breithardt G; Gradaus R
    Europace; 2007 Aug; 9(8):681-6. PubMed ID: 17507354
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictors of appropriate defibrillator therapy among patients with an implantable defibrillator that delivers cardiac resynchronization therapy.
    Desai AD; Burke MC; Hong TE; Kim S; Salem Y; Yong PG; Knight BP
    J Cardiovasc Electrophysiol; 2006 May; 17(5):486-90. PubMed ID: 16684019
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictors of death and occurrence of appropriate implantable defibrillator therapies in patients with ischemic cardiomyopathy.
    Ng AC; Bertini M; Borleffs CJ; Delgado V; Boersma E; Piers SR; Thijssen J; Nucifora G; Shanks M; Ewe SH; Biffi M; van de Veire NR; Leung DY; Schalij MJ; Bax JJ
    Am J Cardiol; 2010 Dec; 106(11):1566-73. PubMed ID: 21094356
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of the implantable defibrillator among elderly patients with a history of life-threatening ventricular arrhythmias.
    Healey JS; Hallstrom AP; Kuck KH; Nair G; Schron EP; Roberts RS; Morillo CA; Connolly SJ
    Eur Heart J; 2007 Jul; 28(14):1746-9. PubMed ID: 17283003
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recurrence of ventricular arrhythmias in patients with non-ischaemic dilated cardiomyopathy: evidence-based predictors.
    Dułak E; Lubiński A; Bissinger A; Przybylski A; Sterlinski M; Filipecki A; Pazdyga A; Zienciuk A; Kempa M; Królak T; Szwed H; Trusz-Gluza M; Kargul W
    Kardiol Pol; 2009 Aug; 67(8):837-44. PubMed ID: 19784881
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of gender on mortality or appropriate shock in patients with nonischemic cardiomyopathy who have implantable cardioverter-defibrillators.
    Chen HA; Hsia HH; Vagelos R; Fowler M; Wang P; Al-Ahmad A
    Pacing Clin Electrophysiol; 2007 Mar; 30(3):390-4. PubMed ID: 17367359
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Death without prior appropriate implantable cardioverter-defibrillator therapy: a competing risk study.
    Koller MT; Schaer B; Wolbers M; Sticherling C; Bucher HC; Osswald S
    Circulation; 2008 Apr; 117(15):1918-26. PubMed ID: 18391108
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictors of all-cause mortality for patients with chronic Chagas' heart disease receiving implantable cardioverter defibrillator therapy.
    Cardinalli-Neto A; Bestetti RB; Cordeiro JA; Rodrigues VC
    J Cardiovasc Electrophysiol; 2007 Dec; 18(12):1236-40. PubMed ID: 17900257
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship between New York Heart Association class change and ventricular tachyarrhythmia occurrence in patients treated with cardiac resynchronization plus defibrillator.
    Lepillier A; Piot O; Gerritse B; Copie X; Lavergne T; Paziaud O; Lascault G; Waintraub X; Otmani A; Le Heuzey JY
    Europace; 2009 Jan; 11(1):80-5. PubMed ID: 18952828
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improved survival associated with prophylactic implantable defibrillators in elderly patients with prior myocardial infarction and depressed ventricular function: a MADIT-II substudy.
    Huang DT; Sesselberg HW; McNitt S; Noyes K; Andrews ML; Hall WJ; Dick A; Daubert JP; Zareba W; Moss AJ;
    J Cardiovasc Electrophysiol; 2007 Aug; 18(8):833-8. PubMed ID: 17537209
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term follow-up of implantable cardioverter-defibrillator for secondary prevention in chagas' heart disease.
    Martinelli M; de Siqueira SF; Sternick EB; Rassi A; Costa R; Ramires JA; Kalil Filho R
    Am J Cardiol; 2012 Oct; 110(7):1040-5. PubMed ID: 22727179
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic utility of microvolt T-wave alternans in risk stratification of patients with ischemic cardiomyopathy.
    Chow T; Kereiakes DJ; Bartone C; Booth T; Schloss EJ; Waller T; Chung ES; Menon S; Nallamothu BK; Chan PS
    J Am Coll Cardiol; 2006 May; 47(9):1820-7. PubMed ID: 16682307
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Poor prognosis for patients with chronic kidney disease despite ICD therapy for the primary prevention of sudden death.
    Cuculich PS; Sánchez JM; Kerzner R; Greenberg SL; Sengupta J; Chen J; Faddis MN; Gleva MJ; Smith TW; Lindsay BD
    Pacing Clin Electrophysiol; 2007 Feb; 30(2):207-13. PubMed ID: 17338717
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Arrhythmic death in implantable cardioverter defibrillator patients: a long-term study over a 10 year implantation period.
    Duray GZ; Schmitt J; Richter S; Israel CW; Hohnloser SH
    Europace; 2009 Nov; 11(11):1462-8. PubMed ID: 19797255
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of ventricular fibrillation rather than ventricular tachycardia predicts tachyarrhythmia recurrences in patients with idiopathic dilated cardiomyopathy and implantable cardioverter defibrillator for secondary prophylaxis.
    Rolf S; Haverkamp W; Borggrefe M; Breithardt G; Bocker D
    Europace; 2009 Mar; 11(3):289-96. PubMed ID: 19095687
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term survival in patients treated with cardiac resynchronization therapy: a 3-year follow-up study from the InSync/InSync ICD Italian Registry.
    Gasparini M; Lunati M; Santini M; Tritto M; Curnis A; Bocchiardo M; Vincenti A; Pistis G; Valsecchi S; Denaro A;
    Pacing Clin Electrophysiol; 2006 Dec; 29 Suppl 2():S2-10. PubMed ID: 17169128
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.